인쇄하기
취소

Sale of new drug for diabetes mellitus approved

Published: 2012-06-29 06:59:00
Updated: 2012-06-29 06:59:00
A newly-developed drug for diabetes mellitus has received approval for production and sale from the authorities.

Gemiglo (gemigliptin), developed by LG Life Sciences, has passed safety and effectiveness tests, becoming the 19th new drug developed by a local pharmaceutical company, the Korea Food and Drug Administration (KFDA) said Wednesday.

Gemigliptin, previously identified as LC15-0444...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.